EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity

Nikša Drinković, Maja Beus, Rinea Barbir, Željko Debeljak, Blanka Tariba Lovaković, Nikolina Kalčec, Marija Ćurlin, Ana Bekavac, Dunja Gorup, Ivan Mamić, Dario Mandić, Vedran Micek und 4 weitere

Nanoscale · 2024 · 16 (19) · 9412-9425

DOI: 10.1039/d3nr06269d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Nikša Drinković und 15 weiteren Autor:innen. Beteiligte Einrichtung: Polyclinic Drinković, Zagreb, Croatia. Hauptthemen laut MEDLINE: Doxorubicin, Polylactic Acid-Polyglycolic Acid Copolymer, Cardiotoxicity, Rats, Wistar. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Hrvatska Zaklada za Znanost, European Regional Development Fund, H2020 Excellent Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoformulations decrease systemic toxicity effects of antitumor agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPolylactic Acid-Polyglycolic Acid CopolymerCardiotoxicityRats, WistarAnimalsRatsMaleFemaleApoptosisNanoparticlesMyocardiumPolyethylene GlycolsAntibiotics, AntineoplasticHeartLiposomes

Substanzen

DoxorubicinPolylactic Acid-Polyglycolic Acid CopolymerPolyethylene GlycolsAntibiotics, AntineoplasticLiposomesliposomal doxorubicin

Autor:innen und Institutionen

  • Polyclinic Drinković, Zagreb, Croatia.
  • Institute for Medical Research and Occupational Health, Zagreb, Croatia. ivinkovic@imi.hr.
  • JJ Strossmayer University of Osijek, Faculty of Medicine, Osijek, Croatia.
  • University Hospital Osijek, Osijek, Croatia.
  • Croatian Catholic University, Zagreb, Croatia.
  • University of Zagreb, School of Medicine, Zagreb, Croatia.

Förderung

  • Hrvatska Zaklada za Znanost
  • European Regional Development Fund
  • H2020 Excellent Science
  • European Social Fund Plus

Zitieren

APA

Drinković, N., Beus, M., Barbir, R., Debeljak, Ž., Tariba Lovaković, B., Kalčec, N., Ćurlin, M., Bekavac, A., Gorup, D., Mamić, I., Mandić, D., Micek, V., Turčić, P., Günday-Türeli, N., Türeli, E., & Vinković Vrček, I. (2024). Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity. Nanoscale, 16(19), 9412-9425. https://doi.org/10.1039/d3nr06269d

Vancouver

Drinković N, Beus M, Barbir R, Debeljak Ž, Tariba Lovaković B, Kalčec N, et al. Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity. Nanoscale. 2024;16(19):9412-9425. doi:10.1039/d3nr06269d

BibTeX
@article{Drinkovi2024,
  author = {Drinković, Nikša and Beus, Maja and Barbir, Rinea and Debeljak, Željko and Tariba Lovaković, Blanka and Kalčec, Nikolina and Ćurlin, Marija and Bekavac, Ana and Gorup, Dunja and Mamić, Ivan and Mandić, Dario and Micek, Vedran and Turčić, Petra and Günday-Türeli, Nazende and Türeli, Emre and Vinković Vrček, Ivana},
  title = {Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity},
  journal = {Nanoscale},
  year = {2024},
  volume = {16},
  number = {19},
  pages = {9412--9425},
  doi = {10.1039/d3nr06269d}
}
Kostenlos starten →